<DOC>
	<DOCNO>NCT00504465</DOCNO>
	<brief_summary>To compare sequential dinoprostone oxytocin induction labor term intact membrane unripe cervix two simultaneous regimen . Our aim confirm finding small trial add data fetal safety .</brief_summary>
	<brief_title>Combined Agent Randomized Trial Induction Labor</brief_title>
	<detailed_description>This study non-blinded , three arm randomize trial 3 site . Entry criterion : &gt; 36 week ’ singleton , cephalic gestation intact membrane unripe cervix ( Bishop ’ score &lt; 6 ) . Study arm : 1 ) dinoprostone vaginal insert ( Cervidil ) 12 hour follow oxytocin , 2 ) dinoprostone vaginal insert ( Cervidil ) 12 hour simultaneous oxytocin , 3 ) intracervical dinoprostone gel ( Prepidil ) ( one dose ) follow immediate oxytocin . Primary outcome measure rate vaginal delivery &lt; 24 hour . Secondary outcome randomization delivery interval , rate cesarean delivery ( CD ) non reassure fetal status ( NRFS ) rate uterine hyperstimulation .</detailed_description>
	<mesh_term>Oxytocin</mesh_term>
	<mesh_term>Dinoprostone</mesh_term>
	<criteria>&gt; = 36 week gestation Singleton fetus Cephalic presentation Intact membranes unripe cervix ( Bishop score &lt; 6 ) Multifetal gestation Rupture membranes Ripe cervix ( Bishop score &gt; 6 ) Active labor Contraindication vaginal delivery Previous uterine surgery Noncephalic presentation Fetal macrosomia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Labor</keyword>
	<keyword>Labor induction</keyword>
	<keyword>Cervical ripening</keyword>
	<keyword>Dinoprostone</keyword>
	<keyword>Fetal safety</keyword>
	<keyword>Oxytocin</keyword>
	<keyword>Cesarean delivery</keyword>
</DOC>